10 Mar 2021 DolPHIN2 Infographic The DolPHIN 2 Clinical Trial is designed to yield high-quality evidence on the efficacy and safety of dolutegravir in late presenting pregnant women, to allow definitive recommendations for use of dolutegravir to reduce MTCT in this high-risk scenario.
03 Dec 2019 HIV on Trial Meet our research team, hear from some of our research participants and learn more about the DolPHIN story so far.
